Nadler Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Hold |
2,010
| – | – | 0.02% | 123 |
|
|
2025
Q1 | $225K | Buy |
+2,010
| New | +$225K | 0.02% | 113 |
|
|
2023
Q2 | – | Sell |
-2,640
| Closed | -$219K | – | 118 |
|
|
2023
Q1 | $219K | Hold |
2,640
| – | – | 0.03% | 104 |
|
|
2022
Q4 | $227K | Buy |
+2,640
| New | +$227K | 0.04% | 99 |
|
|
2022
Q1 | – | Sell |
-3,147
| Closed | -$229K | – | 129 |
|
|
2021
Q4 | $229K | Hold |
3,147
| – | – | 0.03% | 118 |
|
|
2021
Q3 | $220K | Hold |
3,147
| – | – | 0.04% | 115 |
|
|
2021
Q2 | $217K | Buy |
+3,147
| New | +$217K | 0.04% | 123 |
|
|
2020
Q3 | – | Sell |
-2,692
| Closed | -$207K | – | 102 |
|
|
2020
Q2 | $207K | Buy |
+2,692
| New | +$207K | 0.05% | 95 |
|
|
2016
Q4 | – | Sell |
-2,804
| Closed | -$222K | – | 84 |
|
|
2016
Q3 | $222K | Sell |
2,804
-1,031
| -27% | -$81.6K | 0.09% | 73 |
|
|
2016
Q2 | $320K | Sell |
3,835
-42
| -1% | -$3.51K | 0.14% | 59 |
|
|
2016
Q1 | $356K | Buy |
3,877
+211
| +6% | +$19.4K | 0.16% | 53 |
|
|
2015
Q4 | $371K | Buy |
3,666
+19
| +0.5% | +$1.92K | 0.17% | 51 |
|
|
2015
Q3 | $358K | Buy |
3,647
+696
| +24% | +$68.3K | 0.18% | 53 |
|
|
2015
Q2 | $345K | Sell |
2,951
-154
| -5% | -$18K | 0.16% | 54 |
|
|
2015
Q1 | $305K | Buy |
3,105
+405
| +15% | +$39.8K | 0.15% | 60 |
|
|
2014
Q4 | $255K | Buy |
2,700
+590
| +28% | +$55.7K | 0.13% | 68 |
|
|
2014
Q3 | $225K | Buy |
+2,110
| New | +$225K | 0.13% | 70 |
|